Home/Filings/4/0001144204-19-019054
4//SEC Filing

FAVISH MICHAEL 4

Accession 0001144204-19-019054

CIK 0001642375other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 4:05 PM ET

Size

8.4 KB

Accession

0001144204-19-019054

Insider Transaction Report

Form 4
Period: 2019-04-09
FAVISH MICHAEL
DirectorChair, Chief Executive Officer10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-04-09+1,250,0001,250,000 total
    Exercise: $4.40Exp: 2024-04-09Common Stock (1,250,000 underlying)
  • Award

    Common Stock

    2019-04-09$4.00/sh+1,000$4,0001,000 total
Holdings
  • Common Stock

    (indirect: By Trust)
    3,117,647
  • Common Stock

    (indirect: By Spouse)
    130,000
Footnotes (1)
  • [F1]The Option shall vest ratably over three years commencing one twelfth on June 30, 2019, and one twelfth at the end of each calendar quarter thereafter until fully vested.

Issuer

Guardion Health Sciences, Inc.

CIK 0001642375

Entity typeother

Related Parties

1
  • filerCIK 0001255541

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:05 PM ET
Size
8.4 KB